Last $4.28 USD
Change Today +0.19 / 4.65%
Volume 1.1M
ZIOP On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James O. Armitage M.D., F.A.C.P., F.R.C.P.

Member of Scientific/Medical Advisory Board, ZIOPHARM Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 39 board members in 4 different organizations across 3 different industries.

See Board Relationships
67--

Background*

Dr. James O. Armitage, M.D., F.A.C.P., F.R.C.P., served as Dean of College of Medicine of University of Nebraska Medical Center from 2000 to 2003. Dr. Armitage served at the University of Nebraska Medical Center in a variety of leadership roles and served as its Vice Chairman of the Department of Medicine from 1982 to 1990 and Henry J. Lehnhoff Chairman of Department of Internal Medicine from 1990 to 1999. He served as President of ASCO. He served as Director of the ...

Read Full Background

Corporate Headquarters*

Parris Building
Boston, Massachusetts 02129

United States

Phone: 617-259-1970
Fax: 617-241-2855

Board Members Memberships*

Director
2006-2008
Former Director and Member of Science & Technology Committee
2013-Present
Director and Member of Compensation Committee

Education*

BS
University of Nebraska - Lincoln
MD
University of Nebraska, Omaha

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZIOP:US $4.28 USD +0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$436.8K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
--
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIOPHARM ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.